- About Lung Cancer
- Support & Resources
- Make a Difference
On Thursday, November 14, 2013, Lung Cancer Alliance (LCA), along with 12 other advocacy groups, submitted a letter to Congress encouraging them to rethink policy proposals that will lead to lung cancer screening reimbursement cuts and reduced Medicare coverage for diagnostic tests. LCA asked Congress to consider the life-saving benefits of the medical imaging and how reducing coverage and cutting reimbursements will affect patient access to the benefits of early detection and treatment. Reimbursement cuts have a direct impact on access to care in that healthcare providers will be forced to consolidate practices or close, resulting in longer wait time and farther distance for patients to travel. Additionally, imaging providers will be forced to prolong the life of older equipment, decreasing patient access to new and effective imaging technologies.
It is imperative that Congress holds the Centers for Medicare & Medicaid Services (CMS) accountable for ensuring that high risk individuals have full access to high quality imaging equipment, healthcare teams, and diagnostic treatment.
To read the complete letter click here.